Stay updated on Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedRevision metadata updated from v3.4.0 to v3.4.1; no visible changes to page content or functionality, and to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page now shows a glossary and a 'Last Update Submitted that Met QC Criteria' field, and the FEAR Act label reads 'No FEAR Act Data' with a new revision 3.4.0. The previous capitalization and wording—'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'—along with revision 3.3.4 are removed.SummaryDifference0.1%

- Check16 days agoChange DetectedAdded a 'Last Update Posted' label and removed the 'Last Update Posted (Estimated)' label. This change affects only timestamp display and does not modify study data or page functionality.SummaryDifference0.0%

- Check23 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. This is a small metadata update with no impact on page content or behavior.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded a consolidated Locations section listing participating sites by state (Arizona, California, Connecticut, Florida, Indiana, Massachusetts, New York, North Carolina, Oregon, Pennsylvania, Tennessee, Texas, Washington), replacing the previous per-state location blocks. Updated page revision to v3.3.3.SummaryDifference1.0%

- Check72 days agoChange DetectedPublications section now states that entries are automatically filled from PubMed and updates the revision label to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.